APA (7th ed.) Citation

KM, B., JW, L., E, G., A, A., JT, B., AT, F., . . . M, P. (2021). Relationship between Tumor Mutational Burden, PD-L1, Patient Characteristics, and Response to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma. Cancers, 13(22), . https://doi.org/10.3390/cancers13225733

Chicago Style (17th ed.) Citation

KM, Burcher, et al. "Relationship Between Tumor Mutational Burden, PD-L1, Patient Characteristics, and Response to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma." Cancers 13, no. 22 (2021). https://doi.org/10.3390/cancers13225733.

MLA (9th ed.) Citation

KM, Burcher, et al. "Relationship Between Tumor Mutational Burden, PD-L1, Patient Characteristics, and Response to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma." Cancers, vol. 13, no. 22, 2021, https://doi.org/10.3390/cancers13225733.